Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Finetti

Showing results (151-160 of 180) with videos related to

Pageof 18
Sort By:
Oncotarget|October 19, 2018
Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancerMathilde Guerin, Anthony Gonçalves, Yves Toiron, et al.
Oncogene|February 20, 2004
Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parametersFrançois Bertucci, Sébastien Salas, Séverine Eysteries, et al.
Breast Cancer Research and Treatment|November 23, 2015
Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3aAdam R Wolfe, Bisrat G Debeb, Lara Lacerda, et al.
Cell Death & Disease|February 3, 2022
BMI1 nuclear location is critical for RAD51-dependent response to replication stress and drives chemoresistance in breast cancer stem cellsViolette Azzoni, Julien Wicinski, Manon Macario, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2021
Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal AdenocarcinomaDavid J Birnbaum, Sebastian K S Begg, Pascal Finetti, et al.
Molecular Oncology|August 3, 2021
Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasionEmilly S Villodre, Xiaoding Hu, Richard Larson, et al.
Breast Cancer Research : BCR|November 27, 2013
Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancersHiroko Masuda, Keith A Baggerly, Ying Wang, et al.
EMBO Molecular Medicine|September 3, 2019
A genome-wide RNAi screen reveals essential therapeutic targets of breast cancer stem cellsAbir Arfaoui, Claire Rioualen, Violette Azzoni, et al.
Oncotarget|February 28, 2016
MMP2 and MMP9 serum levels are associated with favorable outcome in patients with inflammatory breast cancer treated with bevacizumab-based neoadjuvant chemotherapy in the BEVERLY-2 studyEmeline Tabouret, François Bertucci, Jean-Yves Pierga, et al.
Nature Communications|January 13, 2016
Identification of p62/SQSTM1 as a component of non-canonical Wnt VANGL2-JNK signalling in breast cancerTania M Puvirajesinghe, François Bertucci, Ashish Jain, et al.
Pageof 18

Showing results (151-160 of 180) with videos related to

Sort By:
Pageof 18
Oncotarget|October 19, 2018
Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancerMathilde Guerin, Anthony Gonçalves, Yves Toiron, et al.
Oncogene|February 20, 2004
Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parametersFrançois Bertucci, Sébastien Salas, Séverine Eysteries, et al.
Breast Cancer Research and Treatment|November 23, 2015
Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3aAdam R Wolfe, Bisrat G Debeb, Lara Lacerda, et al.
Cell Death & Disease|February 3, 2022
BMI1 nuclear location is critical for RAD51-dependent response to replication stress and drives chemoresistance in breast cancer stem cellsViolette Azzoni, Julien Wicinski, Manon Macario, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2021
Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal AdenocarcinomaDavid J Birnbaum, Sebastian K S Begg, Pascal Finetti, et al.
Molecular Oncology|August 3, 2021
Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasionEmilly S Villodre, Xiaoding Hu, Richard Larson, et al.
Breast Cancer Research : BCR|November 27, 2013
Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancersHiroko Masuda, Keith A Baggerly, Ying Wang, et al.
EMBO Molecular Medicine|September 3, 2019
A genome-wide RNAi screen reveals essential therapeutic targets of breast cancer stem cellsAbir Arfaoui, Claire Rioualen, Violette Azzoni, et al.
Oncotarget|February 28, 2016
MMP2 and MMP9 serum levels are associated with favorable outcome in patients with inflammatory breast cancer treated with bevacizumab-based neoadjuvant chemotherapy in the BEVERLY-2 studyEmeline Tabouret, François Bertucci, Jean-Yves Pierga, et al.
Nature Communications|January 13, 2016
Identification of p62/SQSTM1 as a component of non-canonical Wnt VANGL2-JNK signalling in breast cancerTania M Puvirajesinghe, François Bertucci, Ashish Jain, et al.
Pageof 18